21 results on '"Neduva, V"'
Search Results
2. A global protein Kinase and phosphatase interaction network in yeast: B3.05
- Author
-
Neduva, V., Breitkreutz, A., Choi, H., Sharom, J., Boucher, L., Larsen, B., Lin, Z.-Y., Stark, C., Breitkreutz, B.-J., Almeida, R., X., Tang J., Dewar, D., Pawson, A., Gingras, A.-C., Nesvizhskii, A., and Tyers, M.
- Published
- 2010
3. Comprehensive Clonal Mapping of Hematopoiesis in Vivo in Humans By Retroviral Vector Insertional Barcoding
- Author
-
Biasco L, Scala S., Dionisio F., Calabria A., Basso Ricci L., Scaramuzza S., Baricordi C., Giannelli S., Neduva V. X., Dow D. J., Pellin D., Di Serio C., Montini E., Naldini L., Aiuti A., VICARD, Paola, Biasco, L, Scala, S., Dionisio, F., Calabria, A., Basso Ricci, L., Scaramuzza, S., Baricordi, C., Giannelli, S., Neduva, V. X., Dow, D. J., Pellin, D., Vicard, Paola, Di Serio, C., Montini, E., Naldini, L., and Aiuti, A.
- Published
- 2014
4. Lentivirus-based Gene Therapy of Hematopoietic Stem Cells in Wiskott-Aldrich Syndrome
- Author
-
Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese M.P, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello M.C, Bosticardo M, Evangelio C. , Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow D.J, Galy A, Miniero R, Finocchi A, Metin A, Banerjee P, Orange J, Galimberti S, Valsecchi M.G, Biffi A, Montini E, Villa A, Ciceri F, Roncarolo M.G, and Naldini L.
- Published
- 2013
5. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- Author
-
Biffi A, Montini E, Lorioli L, Cesani M, Fumagalli F, Plati T, Baldoli C, Martino S, Calabria A, Canale Sabrina, Benedicenti F, Vallanti G, Biasco L, Leo S, Kabbara N, Zanetti G, Rizzo W.B, Nalini A. L. Mehta N.A.L, Cicalese M.P, Casiraghi M, Boelens J.B, Del Carro U, Dow D.J, Schmidt M, Assanelli, A, Neduva V, Di Serio C, Stupka E, Gardner J, von Kalle C, Bordignon C, Ciceri F, Rovelli A, Roncarolo M.G, Aiuti A, Sessa M, and Naldini L.
- Published
- 2013
6. Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome
- Author
-
Aiuti, A, Biasco, L, Scaramuzza, S, Ferrua, F, Cicalese, M, Baricordi, C, Dionisio, F, Calabria, A, Giannelli, S, Castiello, M, Bosticardo, M, Evangelio, C, Assanelli, A, Casiraghi, M, Di Nunzio, S, Callegaro, L, Benati, C, Rizzardi, P, Pellin, D, Di Serio, C, Schmidt, M, Von Kalle, C, Gardner, J, Mehta, N, Neduva, V, Dow, D, Galy, A, Miniero, R, Finocchi, A, Metin, A, Banerjee, P, Orange, J, Galimberti, S, Valsecchi, M, Biffi, A, Montini, E, Villa, A, Ciceri, F, Roncarolo, M, Naldini, L, GALIMBERTI, STEFANIA, VALSECCHI, MARIA GRAZIA, Naldini, L., Aiuti, A, Biasco, L, Scaramuzza, S, Ferrua, F, Cicalese, M, Baricordi, C, Dionisio, F, Calabria, A, Giannelli, S, Castiello, M, Bosticardo, M, Evangelio, C, Assanelli, A, Casiraghi, M, Di Nunzio, S, Callegaro, L, Benati, C, Rizzardi, P, Pellin, D, Di Serio, C, Schmidt, M, Von Kalle, C, Gardner, J, Mehta, N, Neduva, V, Dow, D, Galy, A, Miniero, R, Finocchi, A, Metin, A, Banerjee, P, Orange, J, Galimberti, S, Valsecchi, M, Biffi, A, Montini, E, Villa, A, Ciceri, F, Roncarolo, M, Naldini, L, GALIMBERTI, STEFANIA, VALSECCHI, MARIA GRAZIA, and Naldini, L.
- Abstract
Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after reduced-intensity conditioning regimen. All three patients showed stable engraftment of WASP-expressing cells and improvements in platelet counts, immune functions, and clinical score. Vector integration analyses revealed highly polyclonal and multilineage haematopoiesis resulting from the gene-corrected HSPCs. Lentiviral gene therapy did not induce selection of integrations near oncogenes, and no aberrant clonal expansion was observed after 20 to 32 months. Although extended clinical observation is required to establish long-term safety, lentiviral gene therapy represents a promising treatment for WAS
- Published
- 2013
7. DILIMOT: discovery of linear motifs in proteins
- Author
-
Neduva, V., primary and Russell, R. B., additional
- Published
- 2006
- Full Text
- View/download PDF
8. Clonal tracking of engineered human hematopoiesis through integration sites analysis
- Author
-
Scala, S., Pellin, D., Basso-Ricci, L., Dionisio, F., Baricordi, C., Leonardelli, L., Scaramuzza, S., Ferrua, F., Cicalese, M. P., Giannelli, S., Neduva, V., Dow, D. J., Roncarolo, M. G., Ciceri, F., Vicard, P., Wit, E., Di Serio, C., Bonini, C., Naldini, L., Aiuti, A., Biasco, L., and Stochastic Studies and Statistics
9. In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases
- Author
-
Samantha Scaramuzza, Paola Vicard, Serena Scala, Francesca Ferrua, David J. Dow, Fabio Ciceri, Luca Biasco, Danilo Pellin, Ernst Wit, Luca Basso-Ricci, Clelia Di Serio, Alessandro Aiuti, Luigi Naldini, Maria Grazia Roncarolo, Maria Pia Cicalese, Lorena Leonardelli, Christof von Kalle, Stefania Giannelli, Victor Neduva, Cristina Baricordi, Francesca Dionisio, Manfred Schmidt, Biasco, L, Pellin, D, Scala, S, Dionisio, F, Basso-Ricci, L, Leonardelli, L, Scaramuzza, S, Baricordi, C, Ferrua, F, Cicalese, Mp, Giannelli, S, Neduva, V, Dow, Dj, Schmidt, M, Von Kalle, C, Roncarolo, Mg, Ciceri, F, Vicard, P, Wit, E, Di Serio, C, Naldini, L, Aiuti, A, Biasco, Luca, Pellin, Danilo, Scala, Serena, Dionisio, Francesca, Basso Ricci, Luca, Leonardelli, Lorena, Scaramuzza, Samantha, Baricordi, Cristina, Ferrua, Francesca, Cicalese, Maria Pia, Giannelli, Stefania, Neduva, Victor, Dow, David J., Schmidt, Manfred, Von Kalle, Christof, Roncarolo, Maria Grazia, Ciceri, Fabio, Vicard, Paola, Wit, Ernst, Di Serio, Clelia, Naldini, Luigi, Aiuti, Alessandro, Stochastic Studies and Statistics, Cicalese, MP, Dow, DJ, and Roncarolo, MG
- Subjects
0301 basic medicine ,Male ,Time Factors ,Wiskott–Aldrich syndrome ,Genetic enhancement ,Antigens, CD34 ,Biology ,Viral vector ,03 medical and health sciences ,0302 clinical medicine ,Short Article ,medicine ,Genetics ,Humans ,Cell Lineage ,Progenitor cell ,Cell Engineering ,Progenitor ,Multipotent Stem Cells ,Infant ,Genetic Therapy ,Cell Biology ,medicine.disease ,Hematopoietic Stem Cells ,3. Good health ,Cell biology ,Clone Cells ,Hematopoiesis ,Wiskott-Aldrich Syndrome ,Haematopoiesis ,Mutagenesis, Insertional ,030104 developmental biology ,medicine.anatomical_structure ,Multipotent Stem Cell ,Cell Tracking ,030220 oncology & carcinogenesis ,Child, Preschool ,Immunology ,Molecular Medicine ,Bone marrow - Abstract
Summary Hematopoietic stem/progenitor cells (HSPCs) are capable of supporting the lifelong production of blood cells exerting a wide spectrum of functions. Lentiviral vector HSPC gene therapy generates a human hematopoietic system stably marked at the clonal level by vector integration sites (ISs). Using IS analysis, we longitudinally tracked >89,000 clones from 15 distinct bone marrow and peripheral blood lineages purified up to 4 years after transplant in four Wiskott-Aldrich syndrome patients treated with HSPC gene therapy. We measured at the clonal level repopulating waves, populations' sizes and dynamics, activity of distinct HSPC subtypes, contribution of various progenitor classes during the early and late post-transplant phases, and hierarchical relationships among lineages. We discovered that in-vitro-manipulated HSPCs retain the ability to return to latency after transplant and can be physiologically reactivated, sustaining a stable hematopoietic output. This study constitutes in vivo comprehensive tracking in humans of hematopoietic clonal dynamics during the early and late post-transplant phases., Graphical Abstract, Highlights • Hematopoietic reconstitution occurs in two distinct clonal waves • A few thousand HSPC clones stably sustain multilineage blood cell production • Steady-state hematopoiesis after transplant is maintained by both HSCs and MPPs • Natural killer clones have closer relationships to myeloid cells than to lymphoid cells, Biasco et al. report a clonal tracking study on the dynamics and nature of hematopoietic reconstitution in humans after transplant. Using integration sites as molecular tags, they measured, in gene therapy patients, repopulating waves, population size and dynamics, activity of progenitor subtypes during the early and late post-transplant phases, and hierarchical relationships among lineages.
- Published
- 2016
10. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome
- Author
-
Maria Grazia Valsecchi, Fabio Ciceri, Jason P. Gardner, Anne Galy, Andrea Finocchi, Clelia Di Serio, Anna Villa, Alessandro Aiuti, Danilo Pellin, Paolo Rizzardi, David J. Dow, Marita Bosticardo, Jordan S. Orange, Maria Pia Cicalese, Stefania Giannelli, Pinaki P. Banerjee, Maria Grazia Roncarolo, Luigi Naldini, Victor Neduva, Luca Biasco, Ayse Metin, Roberto Miniero, Alessandra Biffi, Francesca Ferrua, Stefania Galimberti, Manfred G. Schmidt, Samantha Scaramuzza, Sara Di Nunzio, Maria Carmina Castiello, Miriam Casiraghi, Francesca Dionisio, Luciano Callegaro, Cristina Baricordi, Andrea Assanelli, Nalini Mehta, Eugenio Montini, Andrea Calabria, Claudia Benati, Christof von Kalle, Costanza Evangelio, Aiuti, Alessandro, Biasco, L, Scaramuzza, S, Ferrua, F, Cicalese, Mp, Baricordi, C, Dionisio, F, Calabria, A, Giannelli, S, Castiello, Mc, Bosticardo, M, Evangelio, C, Assanelli, A, Casiraghi, M, Di Nunzio, S, Callegaro, L, Benati, C, Rizzardi, P, Pellin, D, DI SERIO, Mariaclelia, Schmidt, M, Von Kalle, C, Gardner, J, Mehta, N, Neduva, V, Dow, Dj, Galy, A, Miniero, R, Finocchi, A, Metin, A, Banerjee, Pp, Orange, J, Galimberti, S, Valsecchi, Mg, Biffi, A, Montini, E, Villa, A, Ciceri, Fabio, Roncarolo, MARIA GRAZIA, Naldini, Luigi, IRCCS San Raffaele Scientific Institute [Milan, Italie], Hematology and BMT Unit, San Raffaele Scientific Institute, Unit of Lymphoid Malignancies, CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie moléculaire et biothérapies innovantes (IMBI), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université d'Évry-Val-d'Essonne (UEVE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Généthon, Ospedale San Raffaele, École pratique des hautes études (EPHE), Biasco, Luca, Scaramuzza, Samantha, Ferrua, Francesca, Cicalese, Maria Pia, Baricordi, Cristina, Dionisio, Francesca, Calabria, Andrea, Giannelli, Stefania, Castiello, Maria Carmina, Bosticardo, Marita, Evangelio, Costanza, Assanelli, Andrea, Casiraghi, Miriam, Di Nunzio, Sara, Callegaro, Luciano, Benati, Claudia, Rizzardi, Paolo, Pellin, Danilo, Di Serio, Clelia, Schmidt, Manfred, Von Kalle, Christof, Gardner, Jason, Mehta, Nalini, Neduva, Victor, Dow, David J., Galy, Anne, Miniero, Roberto, Finocchi, Andrea, Metin, Ayse, Banerjee, Pinaki P., Orange, Jordan S., Galimberti, Stefania, Valsecchi, Maria Grazia, Biffi, Alessandra, Montini, Eugenio, Villa, Anna, Roncarolo, Maria Grazia, Aiuti, A, Cicalese, M, Castiello, M, Di Serio, C, Dow, D, Banerjee, P, Valsecchi, M, Ciceri, F, Roncarolo, M, Naldini, L, and Généthon
- Subjects
Male ,Wiskott–Aldrich syndrome ,medicine.medical_treatment ,Genetic enhancement ,Hematopoietic Stem Cells/*metabolism ,[SDV]Life Sciences [q-bio] ,Hematopoietic stem cell transplantation ,Genetic Therapy/*methods ,0302 clinical medicine ,Transduction, Genetic ,Child ,0303 health sciences ,Multidisciplinary ,biology ,Wiskott–Aldrich syndrome protein ,Hematopoietic Stem Cell Transplantation ,Hematopoietic stem cell ,Gene Therapy ,3. Good health ,Wiskott-Aldrich Syndrome ,Haematopoiesis ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,[SDV.IMM]Life Sciences [q-bio]/Immunology ,Genetic Vector ,Wiskott-Aldrich Syndrome Protein ,Human ,Virus Integration ,Genetic Vectors ,Wiskott-Aldrich Syndrome/*therapy ,Wiskott-Aldrich Syndrome Protein/*genetics ,Lentiviru ,Viral vector ,03 medical and health sciences ,Transduction ,Genetic ,medicine ,Humans ,Progenitor cell ,030304 developmental biology ,Settore MED/38 - Pediatria Generale e Specialistica ,business.industry ,Lentivirus ,Hematopoietic Stem Cell ,Genetic Therapy ,medicine.disease ,Hematopoietic Stem Cells ,Immunology ,biology.protein ,business - Abstract
Next-Generation Gene Therapy Few disciplines in contemporary clinical research have experienced the high expectations directed at the gene therapy field. However, gene therapy has been challenging to translate to the clinic, often because the therapeutic gene is expressed at insufficient levels in the patient or because the gene delivery vector integrates near protooncogenes, which can cause leukemia (see the Perspective by Verma ). Biffi et al. ( 1233158 , published online 11 July) and Aiuti et al. ( 1233151 ; published online 11 July) report progress on both fronts in gene therapy trials of three patients with metachromatic leukodystrophy (MLD), a neurodegenerative disorder, and three patients with Wiskott-Aldrich syndrome (WAS), an immunodeficiency disorder. Optimized lentiviral vectors were used to introduce functional MLD or WAS genes into the patients' hematopoietic stem cells (HSCs) ex vivo, and the transduced cells were then infused back into the patients, who were then monitored for up to 2 years. In both trials, the patients showed stable engraftment of the transduced HSC and high expression levels of functional MLD or WAS genes. Encouragingly, there was no evidence of lentiviral vector integration near proto-oncogenes, and the gene therapy treatment halted disease progression in most patients. A longer follow-up period will be needed to further validate efficacy and safety.
- Published
- 2013
- Full Text
- View/download PDF
11. Lentiviral Hematopoietic Stem Cell Gene Therapy Benefits Metachromatic Leukodystrophy
- Author
-
Simone Leo, Tiziana Plati, Sabrina Canale, Miriam Casiraghi, Laura Lorioli, Nabil Kabbara, Nalini Mehta, Christof von Kalle, Luigi Naldini, Maria Grazia Roncarolo, Fabio Ciceri, Sabata Martino, Luca Biasco, Maria Pia Cicalese, Maria Sessa, Francesca Fumagalli, Jason P. Gardner, Eugenio Montini, Ubaldo Del Carro, Andrea Calabria, Victor Neduva, Attilio Rovelli, Jaap Jan Boelens, Clelia Di Serio, Gianluigi Zanetti, Cristina Baldoli, Martina Cesani, Alessandro Aiuti, Elia Stupka, Fabrizio Benedicenti, Claudio Bordignon, Alessandra Biffi, Manfred Schmidt, Andrea Assanelli, William B. Rizzo, Giuliana Vallanti, David J. Dow, Biffi, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T, Baldoli, C, Martino, S, Calabria, A, Canale, S, Benedicenti, F, Vallanti, G, Biasco, L, Leo, S, Kabbara, N, Zanetti, G, Rizzo, Wb, Mehta, Na, Cicalese, Mp, Casiraghi, M, Boelens, Jj, Del Carro, U, Dow, Dj, Schmidt, M, Assanelli, A, Neduva, V, DI SERIO, Mariaclelia, Stupka, E, Gardner, J, von Kalle, C, Bordignon, Claudio, Ciceri, Fabio, Rovelli, A, Roncarolo, MARIA GRAZIA, Aiuti, Alessandro, Sessa, M, and Naldini, Luigi
- Subjects
Arylsulfatase A ,medicine.medical_treatment ,Genetic enhancement ,Virus Integration ,Genetic Vectors ,lysosomal enzymes ,Hematopoietic stem cell transplantation ,lipid storage restoration ,Biology ,03 medical and health sciences ,Transduction ,0302 clinical medicine ,Genetic ,Transduction, Genetic ,Lysosomal storage disease ,medicine ,Humans ,Cerebroside-Sulfatase ,030304 developmental biology ,0303 health sciences ,Multidisciplinary ,arylsulfatase A activity in CSF ,Leukodystrophy ,Lentivirus ,Hematopoietic Stem Cell Transplantation ,Hematopoietic stem cell ,Brain ,Genetic Therapy ,Leukodystrophy, Metachromatic ,Metachromatic ,medicine.disease ,Hematopoietic Stem Cells ,Magnetic Resonance Imaging ,3. Good health ,Metachromatic leukodystrophy ,Transplantation ,medicine.anatomical_structure ,Treatment Outcome ,Immunology ,Genetic Engineering ,030217 neurology & neurosurgery ,DNA Damage ,Follow-Up Studies - Abstract
Metachromatic leukodystrophy (MLD) is an inherited lysosomal storage disease caused by arylsulfatase A (ARSA) deficiency. Patients with MLD exhibit progressive motor and cognitive impairment and die within a few years of symptom onset. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. After reinfusion of the gene-corrected HSCs, the patients showed extensive and stable ARSA gene replacement, which led to high enzyme expression throughout hematopoietic lineages and in cerebrospinal fluid. Analyses of vector integrations revealed no evidence of aberrant clonal behavior. The disease did not manifest or progress in the three patients 7 to 21 months beyond the predicted age of symptom onset. These findings indicate that extensive genetic engineering of human hematopoiesis can be achieved with lentiviral vectors and that this approach may offer therapeutic benefit for MLD patients. Metachromatic leukodystrophy (MLD) is an inherited lysosomal storage disease caused by arylsulfatase A (ARSA) deficiency. Patients with MLD exhibit progressive motor and cognitive impairment and die within a few years of symptom onset. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. After reinfusion of the gene-corrected HSCs, the patients showed extensive and stable ARSA gene replacement, which led to high enzyme expression throughout hematopoietic lineages and in cerebrospinal fluid. Analyses of vector integrations revealed no evidence of aberrant clonal behavior. The disease did not manifest or progress in the three patients 7 to 21 months beyond the predicted age of symptom onset. These findings indicate that extensive genetic engineering of human hematopoiesis can be achieved with lentiviral vectors and that this approach may offer therapeutic benefit for MLD patients. "\"\\\"\\\\\\\"\\\\\\\\\\\\\\\"\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"Metachromatic leukodystrophy (MLD) is an inherited lysosomal storage disease caused by arylsulfatase A (ARSA) deficiency. Patients with MLD exhibit progressive motor and cognitive impairment and die within a few years of symptom onset. We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. After reinfusion of the gene-corrected HSCs, the patients showed extensive and stable ARSA gene replacement, which led to high enzyme expression throughout hematopoietic lineages and in cerebrospinal fluid. Analyses of vector integrations revealed no evidence of aberrant clonal behavior. The disease did not manifest or progress in the three patients 7 to 21 months beyond the predicted age of symptom onset. These findings indicate that extensive genetic engineering of human hematopoiesis can be achieved with lentiviral vectors and that this approach may offer therapeutic benefit for MLD patients.\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\"\\\\\\\\\\\\\\\"\\\\\\\"\\\"\""
- Published
- 2013
12. In Vivo Tracking of Human Hematopoiesis Reveals Patterns of Clonal Dynamics during Early and Steady-State Reconstitution Phases.
- Author
-
Biasco L, Pellin D, Scala S, Dionisio F, Basso-Ricci L, Leonardelli L, Scaramuzza S, Baricordi C, Ferrua F, Cicalese MP, Giannelli S, Neduva V, Dow DJ, Schmidt M, Von Kalle C, Roncarolo MG, Ciceri F, Vicard P, Wit E, Di Serio C, Naldini L, and Aiuti A
- Subjects
- Antigens, CD34 metabolism, Cell Engineering, Cell Lineage genetics, Child, Preschool, Clone Cells, Genetic Therapy, Hematopoietic Stem Cells cytology, Hematopoietic Stem Cells metabolism, Humans, Infant, Male, Multipotent Stem Cells cytology, Multipotent Stem Cells metabolism, Mutagenesis, Insertional genetics, Time Factors, Wiskott-Aldrich Syndrome genetics, Wiskott-Aldrich Syndrome therapy, Cell Tracking, Hematopoiesis genetics
- Abstract
Hematopoietic stem/progenitor cells (HSPCs) are capable of supporting the lifelong production of blood cells exerting a wide spectrum of functions. Lentiviral vector HSPC gene therapy generates a human hematopoietic system stably marked at the clonal level by vector integration sites (ISs). Using IS analysis, we longitudinally tracked >89,000 clones from 15 distinct bone marrow and peripheral blood lineages purified up to 4 years after transplant in four Wiskott-Aldrich syndrome patients treated with HSPC gene therapy. We measured at the clonal level repopulating waves, populations' sizes and dynamics, activity of distinct HSPC subtypes, contribution of various progenitor classes during the early and late post-transplant phases, and hierarchical relationships among lineages. We discovered that in-vitro-manipulated HSPCs retain the ability to return to latency after transplant and can be physiologically reactivated, sustaining a stable hematopoietic output. This study constitutes in vivo comprehensive tracking in humans of hematopoietic clonal dynamics during the early and late post-transplant phases., (Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
13. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
- Author
-
Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, Dionisio F, Calabria A, Giannelli S, Castiello MC, Bosticardo M, Evangelio C, Assanelli A, Casiraghi M, Di Nunzio S, Callegaro L, Benati C, Rizzardi P, Pellin D, Di Serio C, Schmidt M, Von Kalle C, Gardner J, Mehta N, Neduva V, Dow DJ, Galy A, Miniero R, Finocchi A, Metin A, Banerjee PP, Orange JS, Galimberti S, Valsecchi MG, Biffi A, Montini E, Villa A, Ciceri F, Roncarolo MG, and Naldini L
- Subjects
- Child, Genetic Vectors, Humans, Lentivirus, Male, Transduction, Genetic, Virus Integration, Genetic Therapy methods, Hematopoietic Stem Cell Transplantation, Hematopoietic Stem Cells metabolism, Wiskott-Aldrich Syndrome therapy, Wiskott-Aldrich Syndrome Protein genetics
- Abstract
Wiskott-Aldrich syndrome (WAS) is an inherited immunodeficiency caused by mutations in the gene encoding WASP, a protein regulating the cytoskeleton. Hematopoietic stem/progenitor cell (HSPC) transplants can be curative, but, when matched donors are unavailable, infusion of autologous HSPCs modified ex vivo by gene therapy is an alternative approach. We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen. All three patients showed stable engraftment of WASP-expressing cells and improvements in platelet counts, immune functions, and clinical scores. Vector integration analyses revealed highly polyclonal and multilineage haematopoiesis resulting from the gene-corrected HSPCs. Lentiviral gene therapy did not induce selection of integrations near oncogenes, and no aberrant clonal expansion was observed after 20 to 32 months. Although extended clinical observation is required to establish long-term safety, lentiviral gene therapy represents a promising treatment for WAS.
- Published
- 2013
- Full Text
- View/download PDF
14. An allosteric inhibitor of substrate recognition by the SCF(Cdc4) ubiquitin ligase.
- Author
-
Orlicky S, Tang X, Neduva V, Elowe N, Brown ED, Sicheri F, and Tyers M
- Subjects
- Allosteric Regulation, Models, Molecular, Protein Conformation, Ubiquitin-Protein Ligases antagonists & inhibitors, Ubiquitin-Protein Ligases metabolism
- Abstract
The specificity of SCF ubiquitin ligase-mediated protein degradation is determined by F-box proteins. We identified a biplanar dicarboxylic acid compound, called SCF-I2, as an inhibitor of substrate recognition by the yeast F-box protein Cdc4 using a fluorescence polarization screen to monitor the displacement of a fluorescein-labeled phosphodegron peptide. SCF-I2 inhibits the binding and ubiquitination of full-length phosphorylated substrates by SCF(Cdc4). A co-crystal structure reveals that SCF-I2 inserts itself between the beta-strands of blades 5 and 6 of the WD40 propeller domain of Cdc4 at a site that is 25 A away from the substrate binding site. Long-range transmission of SCF-I2 interactions distorts the substrate binding pocket and impedes recognition of key determinants in the Cdc4 phosphodegron. Mutation of the SCF-I2 binding site abrogates its inhibitory effect and explains specificity in the allosteric inhibition mechanism. Mammalian WD40 domain proteins may exhibit similar allosteric responsiveness and hence represent an extensive class of druggable target.
- Published
- 2010
- Full Text
- View/download PDF
15. A global protein kinase and phosphatase interaction network in yeast.
- Author
-
Breitkreutz A, Choi H, Sharom JR, Boucher L, Neduva V, Larsen B, Lin ZY, Breitkreutz BJ, Stark C, Liu G, Ahn J, Dewar-Darch D, Reguly T, Tang X, Almeida R, Qin ZS, Pawson T, Gingras AC, Nesvizhskii AI, and Tyers M
- Subjects
- Binding Sites, Carbon metabolism, Cell Cycle Proteins metabolism, DNA Damage, MAP Kinase Signaling System, Mass Spectrometry, Metabolic Networks and Pathways, Models, Biological, Nitrogen metabolism, Phosphorylation, Protein Interaction Mapping, Protein Serine-Threonine Kinases metabolism, Protein Subunits metabolism, Protein Tyrosine Phosphatases metabolism, Proteome, Saccharomyces cerevisiae metabolism, Signal Transduction, Phosphoprotein Phosphatases metabolism, Protein Kinases metabolism, Saccharomyces cerevisiae enzymology, Saccharomyces cerevisiae Proteins metabolism
- Abstract
The interactions of protein kinases and phosphatases with their regulatory subunits and substrates underpin cellular regulation. We identified a kinase and phosphatase interaction (KPI) network of 1844 interactions in budding yeast by mass spectrometric analysis of protein complexes. The KPI network contained many dense local regions of interactions that suggested new functions. Notably, the cell cycle phosphatase Cdc14 associated with multiple kinases that revealed roles for Cdc14 in mitogen-activated protein kinase signaling, the DNA damage response, and metabolism, whereas interactions of the target of rapamycin complex 1 (TORC1) uncovered new effector kinases in nitrogen and carbon metabolism. An extensive backbone of kinase-kinase interactions cross-connects the proteome and may serve to coordinate diverse cellular responses.
- Published
- 2010
- Full Text
- View/download PDF
16. Proline-rich regions in transcriptional complexes: heading in many directions.
- Author
-
Neduva V and Russell RB
- Subjects
- Animals, Binding Sites, Mice, Models, Genetic, Nematoda genetics, Proline chemistry, RNA-Binding Protein EWS genetics, Structure-Activity Relationship, Evolution, Molecular, Protein Structure, Tertiary, RNA Splicing, Transcription, Genetic
- Abstract
Although many protein complexes are now known, the precise details of how each component operates are rarely understood. Through a combination of bioinformatics and analysis of gene-trapped mouse clones, Enkhmandakh et al. were able to deduce the modular function for a part of Ssdp1, a crucial component of the Ldb1 transcriptional complex, which plays a central role in mammalian head development. A proline-rich module from Ssdp1 is likely responsible for transactivation, and this region is curiously mobile, occurring in different proteins in different species. The results underscore the importance of protein modularity in complex organization, as well as the role of irregular or disordered parts of proteins in crucial biological processes.
- Published
- 2007
- Full Text
- View/download PDF
17. Peptides mediating interaction networks: new leads at last.
- Author
-
Neduva V and Russell RB
- Subjects
- Binding Sites, Models, Biological, Peptides chemistry, Protein Binding, Protein Conformation, Protein Interaction Mapping methods, Proteins chemistry, Structure-Activity Relationship, Peptides metabolism, Proteins metabolism
- Abstract
A growing number of protein interactions are found to be mediated by a large globular region in one protein binding to a comparatively short, peptide stretch in another. Regions that bind a common protein often show a similar sequence pattern or linear motif that mediates the binding. The past year has seen reports of new techniques that can uncover these motifs directly from interaction data. These studies have suggested that the fraction of interactions mediated by these regions is greater than previously anticipated. Concurrently, other work has demonstrated that it is possible to target these interactions using small molecules. Together these developments hold great promise for future efforts to target chemically precise details of complex systems.
- Published
- 2006
- Full Text
- View/download PDF
18. Systematic discovery of new recognition peptides mediating protein interaction networks.
- Author
-
Neduva V, Linding R, Su-Angrand I, Stark A, de Masi F, Gibson TJ, Lewis J, Serrano L, and Russell RB
- Subjects
- Amino Acid Sequence, Animals, Genome genetics, Humans, Models, Molecular, Molecular Sequence Data, Protein Binding, Protein Structure, Tertiary, Proteins chemistry, Proteins genetics, Peptides metabolism, Proteins metabolism
- Abstract
Many aspects of cell signalling, trafficking, and targeting are governed by interactions between globular protein domains and short peptide segments. These domains often bind multiple peptides that share a common sequence pattern, or "linear motif" (e.g., SH3 binding to PxxP). Many domains are known, though comparatively few linear motifs have been discovered. Their short length (three to eight residues), and the fact that they often reside in disordered regions in proteins makes them difficult to detect through sequence comparison or experiment. Nevertheless, each new motif provides critical molecular details of how interaction networks are constructed, and can explain how one protein is able to bind to very different partners. Here we show that binding motifs can be detected using data from genome-scale interaction studies, and thus avoid the normally slow discovery process. Our approach based on motif over-representation in non-homologous sequences, rediscovers known motifs and predicts dozens of others. Direct binding experiments reveal that two predicted motifs are indeed protein-binding modules: a DxxDxxxD protein phosphatase 1 binding motif with a KD of 22 microM and a VxxxRxYS motif that binds Translin with a KD of 43 microM. We estimate that there are dozens or even hundreds of linear motifs yet to be discovered that will give molecular insight into protein networks and greatly illuminate cellular processes.
- Published
- 2005
- Full Text
- View/download PDF
19. Linear motifs: evolutionary interaction switches.
- Author
-
Neduva V and Russell RB
- Subjects
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Nucleic Acids chemistry, Nucleic Acids genetics, Nucleic Acids metabolism, Amino Acid Motifs, Evolution, Molecular
- Abstract
Linear motifs are short sequence patterns associated with a particular function. They differ fundamentally from longer, globular protein domains in terms of their binding affinities, evolution and in how they are found experimentally or computationally. In this Minireview, we discuss various aspects of these critically important functional regions.
- Published
- 2005
- Full Text
- View/download PDF
20. GlobPlot: Exploring protein sequences for globularity and disorder.
- Author
-
Linding R, Russell RB, Neduva V, and Gibson TJ
- Subjects
- Algorithms, Computer Graphics, Humans, Internet, Models, Molecular, Proteome chemistry, User-Computer Interface, Amino Acid Motifs, Protein Structure, Tertiary, Sequence Analysis, Protein methods, Software
- Abstract
A major challenge in the proteomics and structural genomics era is to predict protein structure and function, including identification of those proteins that are partially or wholly unstructured. Non-globular sequence segments often contain short linear peptide motifs (e.g. SH3-binding sites) which are important for protein function. We present here a new tool for discovery of such unstructured, or disordered regions within proteins. GlobPlot (http://globplot.embl.de) is a web service that allows the user to plot the tendency within the query protein for order/globularity and disorder. We show examples with known proteins where it successfully identifies inter-domain segments containing linear motifs, and also apparently ordered regions that do not contain any recognised domain. GlobPlot may be useful in domain hunting efforts. The plots indicate that instances of known domains may often contain additional N- or C-terminal segments that appear ordered. Thus GlobPlot may be of use in the design of constructs corresponding to globular proteins, as needed for many biochemical studies, particularly structural biology. GlobPlot has a pipeline interface--GlobPipe--for the advanced user to do whole proteome analysis. GlobPlot can also be used as a generic infrastructure package for graphical displaying of any possible propensity.
- Published
- 2003
- Full Text
- View/download PDF
21. The role of identified neurotransmitter systems in the response of insular cortex to unfamiliar taste: activation of ERK1-2 and formation of a memory trace.
- Author
-
Berman DE, Hazvi S, Neduva V, and Dudai Y
- Subjects
- Adrenergic beta-Antagonists administration & dosage, Animals, Cholinergic Antagonists administration & dosage, Cholinergic Antagonists pharmacology, Dopamine Antagonists administration & dosage, Excitatory Amino Acid Antagonists administration & dosage, Male, Memory drug effects, Microinjections, Mitogen-Activated Protein Kinase 3, Muscarinic Antagonists administration & dosage, Neurotransmitter Agents agonists, Neurotransmitter Agents antagonists & inhibitors, Rats, Rats, Wistar, Receptors, AMPA antagonists & inhibitors, Receptors, AMPA metabolism, Receptors, Dopamine metabolism, Receptors, GABA drug effects, Receptors, GABA metabolism, Receptors, Metabotropic Glutamate antagonists & inhibitors, Receptors, Metabotropic Glutamate metabolism, Receptors, Muscarinic metabolism, Receptors, N-Methyl-D-Aspartate antagonists & inhibitors, Receptors, N-Methyl-D-Aspartate metabolism, Reinforcement, Psychology, Cerebral Cortex metabolism, Memory physiology, Mitogen-Activated Protein Kinase 1 metabolism, Mitogen-Activated Protein Kinases metabolism, Neurotransmitter Agents metabolism, Taste physiology
- Abstract
In the behaving rat, the consumption of an unfamiliar taste activates the extracellular signal-regulated kinase 1-2 (ERK1-2) in the insular cortex, which contains the taste cortex. In contrast, consumption of a familiar taste has no effect. Furthermore, activation of ERK1-2, culminating in modulation of gene expression, is obligatory for the encoding of long-term, but not short-term, memory of the new taste (Berman et al., 1998). Which neurotransmitter and neuromodulatory systems are involved in the activation of ERK1-2 by the unfamiliar taste and in the long-term encoding of the new taste information? Here we show, by the use of local microinjections of pharmacological agents to the insular cortex in the behaving rat, that multiple neurotransmitters and neuromodulators are required for encoding of taste memory in cortex. However, these systems vary in the specificity of their role in memory acquisition and in their contribution to the activation of ERK1-2. NMDA receptors, metabotropic glutamate receptors, muscarinic, and beta-adrenergic and dopaminergic receptors, all contribute to the acquisition of the new taste memory but not to its retrieval. Among these, only NMDA and muscarinic receptors specifically mediate taste-dependent activation of ERK1-2, whereas the beta-adrenergic function is independent of ERK1-2, and dopaminergic receptors regulate also the basal level of ERK1-2 activation. The data are discussed in the context of postulated novelty detection circuits in the central taste system.
- Published
- 2000
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.